HONG KONG – (COMMERCIAL THREAD) – Fresenius Medical Care, the world’s leading provider of products and services for people with kidney disease, recently announced the official opening of its first training center in Korea, to offer comprehensive training programs and to share knowledge and experience in renal care, critical care and treatment strategies with healthcare professionals. Training programs and other events at the center will help build collective knowledge within the industry, unlocking the potential for improved patient care.
The opening ceremony on June 24 was chaired by Professor Yang Chulwoo, President of the Korean Society of Nephrology (KSN) and Clare Kim, Managing Director of Fresenius Medical Care Korea, in the presence of members of the KSN Executive Committee.
Fresenius Medical Care Training Center, Korea’s first healthcare education institution to be operated by a supplier of dialysis products, was established to help doctors, nurses and clinical technicians access the latest knowledge and skills in their professional practice. The center offers a dedicated training center for healthcare professionals to undertake training and development programs in Yeouido, downtown Seoul, providing the opportunity to gain hands-on experience with the most advanced medical equipment. from Fresenius Medical Care used for hemodialysis (HD), automated peritoneal dialysis (APD) and continuous renal replacement therapy (CRRT). Certified trainers from Fresenius Medical Care, as well as regional clinical training experts from across Asia-Pacific, will provide best practice training to healthcare professionals in the area of kidney care.
With the opening of the training center, Fresenius Medical Care Korea promises its continued support for the training of healthcare professionals. Regular academic conferences will include the Advanced Renal Education Program (AREP), Fresenius Medical Care Korea’s distinguished education initiative that is held annually for medical professionals in renal care; and the training of nephrology nurses dedicated to the care of dialysis patients. The Fresenius Medical Care Training Center also provides educational opportunities for individual healthcare professionals specializing in particular treatment modalities such as PD, HD and CRRT.
“KSN salutes and appreciates the efforts of Fresenius Medical Care to establish the training center and provide comprehensive training programs for healthcare professionals,” said Professor Yang Chulwoo, President of KSN. “It is expected to make a positive contribution to improving the quality of medical services for patients in Korea in the long term. ”
“The Fresenius Medical Care Training Center will provide healthcare professionals with systematic, high-level training, helping them advance their knowledge and skills in renal and critical care. Said Clare Kim, Managing Director of Fresenius Medical Care Korea. “Going forward, we are committed to providing comprehensive academic programs to support the development of healthcare professionals. We will also continue to provide high quality products and services to meet the needs of patients, the community and the industry.
“As the world’s leading provider of dialysis products and services, and with an advanced critical care portfolio, Fresenius Medical Care is committed to bringing its expertise and experience to our healthcare professional partners in the sector. Supporting their growth and development will help ensure high standards of care for our patients, which in turn will enable us to fulfill our mission – to create a future worth living, for patients, every day. said Harry de Wit, President and CEO of Fresenius Medical Care Asia-Pacific.
ABOUT FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world’s leading provider of products and services for people with kidney disease, with approximately 3.7 million patients worldwide undergoing regular dialysis treatment. Through its network of 4,110 dialysis clinics, Fresenius Medical Care provides dialysis treatment to 344,476 patients worldwide. Fresenius Medical Care is also the leading supplier of dialysis products such as dialysis machines or dialyzers. Along with its main activity, the Renal Care Continuum, the company is focusing on its expansion in complementary areas and in the area of intensive care. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).
For more information, please visit the company’s website at www.freseniusmedicalcare.asia.
This press release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results clinical studies, fluctuations in exchange rates, uncertainties in litigation or investigative procedures and the availability of funding. These and other risks and uncertainties are detailed in the reports of Fresenius Medical Care AG & Co. KGaA filed with the United States Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA assumes no responsibility for updating any forward-looking statements contained in this press release.